Related by context. Frequent words. (Click for all words.) 59 Noonan Russo 58 Stephanie Carrington 56 Investor Relations +#-#-#-# 55 CONTACT Investor Relations 55 Tel +#- 0 54 @ fd.com 52 Investor Inquiries 52 Jason Rando 52 NASDAQ MarketSite Jolene Libretto 52 Disclaimer Deze bekendmaking 51 Investor Relations Contacts 51 Investor Contacts 51 Contacts Investor Relations 51 Brainerd Communicators Inc. 50 Lippert Heilshorn & 50 PondelWilkinson Inc. 50 SVP Investor Relations 50 @ icrinc.com 50 -0 CONTACT 50 Heilshorn & 50 +#-#-#-# Fax +#-#-#-# [002] 50 +#-#-#-# Ext [001] 49 http:/www.presseportal.de Contact 49 Investor Relations Tel 49 +#-#-#-# x# [002] 49 KCSA Worldwide 49 #-# Email Website 49 Media Inquiries 49 Copyright Business Wire 49 Fax +#-#-#-# [003] 49 +#- 0 [002] 48 Tel #.#.# 48 Sard Verbinnen & 48 #-# www.renmarkfinancial.com 48 @ bmo.com 48 Blueshirt Group 48 +#-#-#-# SOURCE [001] 48 #-# FAX Website 48 Editorial Contacts 48 #-#-# ext.# [003] 48 EVC Group 48 Investor Contact 48 Kekst 48 INVESTOR RELATIONS 48 +#-#-#-# ext [001] 48 Fax #.#.# 47 PLEASE CONTACT 47 Tel +# 0 47 MEDIA CONTACTS 47 MEDIA CONTACT 47 Joele Frank Wilkinson Brimmer 47 FINANCIAL TABLES FOLLOW 47 Equicom Group 46 % SEDAR #EF 46 Email Contact 46 FAX Source 46 #-#-# ext.# [002] 46 Investor Relations Contact 46 By Samieh Shalash 46 www.syntapharma.com 46 +# 0 #-#-# [003] 46 Rachelle Morrow #-#-# ext 46 #-# x.# [001] 46 Piacente Group Inc. 46 Media Enquiries 46 www.iteris.com 46 please visit http:/www.capella.edu 45 #-#-#-# Fax 45 @ alvarion.com 45 #-# x# Email 45 Ltd. Tel +#-#-#-# [002] 45 Email SOURCE 45 CONTACT INFORMATION 45 +#-#-#-# [015] 45 Psychol 45 www.cardiome.com 45 Sheila Stuewe DRG 45 +#-#-#-# +#-#-#-# 45 Tel #-#-# ext 45 #-# URL http:/www.newswire.ca/en/releases/arAHDI 45 Jolene Libretto 45 Kim Esq 45 investor.relations @ 45 Tel +#-#-#-# [007] 45 @ att.net 45 Email Website 45 Cerus Corporation 45 www.allos.com 45 #-# ext.# [002] 45 +#- 0 #-#-# [004] 45 +# 0 #-# [005] 45 By Scott Rochat 44 officieel geldend 44 Investor Relations Tel +# 44 PLEASE CALL 44 Preclinical Development 44 www.combinatorx.com 44 www.curis.com 44 NOT ACCEPT RESPONSIBILITY FOR 44 #-# FAX Email 44 Oncolytics please